0 353

Cited 0 times in

동시 항암화학방사선 지료를 받은 자궁경부암 환자에서 squamous cell carcinoma antigen과 예후와의 상관관계

DC Field Value Language
dc.contributor.author김상운-
dc.contributor.author김성훈-
dc.contributor.author김영태-
dc.contributor.author김재욱-
dc.contributor.author김재훈-
dc.contributor.author윤보성-
dc.date.accessioned2017-05-04T07:33:50Z-
dc.date.available2017-05-04T07:33:50Z-
dc.date.issued2005-
dc.identifier.issn1738-6544-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/147469-
dc.description.abstractOBJECTIVE: The aim of this study was to determine the correlation between SCC Ag and the prognosis in cervical cancer patients following concurrent chemoradiotherapy (CCRT). METHODS: The charts of 116 patients following concurrent chemoradiotherapy among 330 patients diagnosed to cervical cancer at Yonsei University Medical Center from Jan. 1998 to June 2003 were reviewed retrospectively. Clinical characteristics (age, parity, body mass index), stage, lesion size, cell type, squamous cell subtype, initial SCC Ag (<1.5 and >or=1.5), posttreatment SCC Ag (<1.5 and >or=1.5) was evaluated with overall survival. Distribution of SCC Ag level before CCRT in relation to FIGO stage and failure pattern in SCC positive patients before CCRT were reviewed. Overall survival was estimated according to respectively, subgroups of initial SCC Ag, SCC Ag after 2nd CCRT and posttreatment SCC Ag. Chi square test and Kaplan Meier test were used for statistical analysis (P<0.05). RESULTS: Overall survival was significantly correlated with only stage (P=0.0014). Two patients (15.4%) among 13 patients with recurrence had SCC Ag<1.5. Subgroups (1.5<or=SCC Ag<5 ng/m, 5 ng/mL<or=SCC Ag<30 ng/mL, 30 ng/mL<or=SCC Ag) of initial SCC Ag, SCC Ag after 2nd CCRT, and posttreatment SCC Ag were significantly correlated with overall survival (P=0.0337, 0.0001, 0.0446, respectively). CONCLUSION: The measurements of the levels of initial SCC Ag, SCC Ag after 2nd CCRT and posttreatment SCC Ag are expected to be useful in predicting the prognosis of the patients with cervical cancer.-
dc.description.statementOfResponsibilityrestriction-
dc.format.extent123~132-
dc.languageKorean-
dc.publisher대한부인종양,콜포스코피학회-
dc.relation.isPartOfKorean Journal of Gynecologic Oncology (부인종양)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHSCC antigen-
dc.subject.MESHCervix cancer-
dc.subject.MESHconcurrent chemoradiotherapy-
dc.subject.MESHprognosis-
dc.title동시 항암화학방사선 지료를 받은 자궁경부암 환자에서 squamous cell carcinoma antigen과 예후와의 상관관계-
dc.title.alternativeCorrelation between SCC antigen and the prognosis of cervical cancer patients following concurrent chemoradiotherapy-
dc.typeArticle-
dc.publisher.locationKorea-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Obstetrics and Gynecology (산부인과학교실)-
dc.contributor.departmentDept. of Obstetrics and Gynecology (산부인과학교실)-
dc.contributor.departmentDept. of Obstetrics and Gynecology (산부인과학교실)-
dc.contributor.departmentDept. of Obstetrics and Gynecology (산부인과학교실)-
dc.contributor.departmentDept. of Obstetrics and Gynecology (산부인과학교실)-
dc.contributor.departmentDept. of Obstetrics and Gynecology (산부인과학교실)-
dc.contributor.googleauthor박수현-
dc.contributor.googleauthor김영태-
dc.contributor.googleauthor김재욱-
dc.contributor.googleauthor김재훈-
dc.contributor.googleauthor김성훈-
dc.contributor.googleauthor윤보성-
dc.contributor.googleauthor김상운-
dc.identifier.doiOAK-2005-02918-
dc.contributor.localIdA00526-
dc.contributor.localIdA00595-
dc.contributor.localIdA00729-
dc.contributor.localIdA00866-
dc.contributor.localIdA00876-
dc.contributor.localIdA02554-
dc.relation.journalcodeJ02020-
dc.relation.journalsince2005~2010-
dc.relation.journalafter2011~ Journal of Gynecologic Oncology-
dc.identifier.urlhttp://kiss.kstudy.com/journal/thesis_name.asp?tname=kiss2002&key=2440803-
dc.relation.journalbefore~2004 Korean Journal of Gynecologic Oncology and Colposcopy (대한부인종양,콜포스코피학회지)-
dc.subject.keywordSCC antigen-
dc.subject.keywordCervix cancer-
dc.subject.keywordconcurrent chemoradiotherapy-
dc.subject.keywordprognosis-
dc.contributor.alternativeNameKim, Sang Wun-
dc.contributor.alternativeNameKim, Sung Hoon-
dc.contributor.alternativeNameKim, Young Tae-
dc.contributor.alternativeNameKim, Jae Wook-
dc.contributor.alternativeNameKim, Jae Hoon-
dc.contributor.alternativeNameYoon, Bo Sung-
dc.citation.volume16-
dc.citation.number2-
dc.citation.startPage123-
dc.citation.endPage132-
dc.identifier.bibliographicCitationKorean Journal of Gynecologic Oncology (부인종양), Vol.16(2) : 123-132, 2005-
dc.date.modified2017-05-04-
dc.identifier.rimsid40250-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.